tm
Seeing Is Believing
tm
Seeing Is Believing
CRDF is currently covered by 4 analysts with an average price target of $8. This is a potential upside of $8.95 (492.59%) from yesterday's end of day stock price of $1.35.
Cardiff Oncology's activity chart (see below) currently has 16 price targets and 30 ratings on display. The stock rating distribution of CRDF is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 7.69% with an average time for these price targets to be met of 42.77 days.
Highest price target for CRDF is $10, Lowest price target is $6, average price target is $8.
Most recent stock forecast was given by from PIPER SANDLER on 25-Feb-2026. First documented stock forecast 18-Sep-2020.
Currently out of the existing stock ratings of CRDF, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Apr-2025
$6
$4.75 (380.00%)
$10
4 months 13 days ago
(25-Feb-2026)
0/3 (0%)
$4.09 (214.14%)
Buy Since 28-Feb-2025
$10
5 months 10 days ago
(28-Jan-2026)
0/2 (0%)
$7.56 (309.84%)
Buy Since 22-Oct-2020
$10
$8.75 (700.00%)
11 months 2 days ago
(06-Aug-2025)
0/7 (0%)
$7.56 (309.84%)
Buy Since 08-Jul-2025
$19
$17.75 (1420.00%)
1 years ago
(08-Jul-2025)
0/1 (0%)
$15.06 (382.23%)
Buy Since 08-Oct-2020
$10
$8.75 (700.00%)
1 years 6 months 25 days ago
(13-Dec-2024)
0/4 (0%)
$6.08 (155.10%)
What is CRDF (Cardiff Oncology) average time for price targets to be met?
Which analyst has the current highest performing score on CRDF (Cardiff Oncology) with a proven track record?
Which analyst has the most public recommendations on CRDF (Cardiff Oncology)?
Which analyst is the currently most bullish on CRDF (Cardiff Oncology)?
Which analyst is the currently most reserved on CRDF (Cardiff Oncology)?
